Skip to main content

Myles Selig Wolf

Charles Johnson, M.D. Distinguished Professor of Medicine
Medicine, Nephrology


The focus of my research is disordered mineral metabolism across the spectrum of chronic kidney disease, including dialysis, kidney transplantation and earlier stages.

My research has been published in leading general medicine and subspecialty journals, including the New England Journal of Medicine, JAMA, the Journal of Clinical Investigation, Circulation, Cell Metabolism, Journal of the American Society of Nephrology, and Kidney International, among others.

My primary contributions have been in the area of hormonal regulation of phosphate homeostasis. I have helped to characterize the physiological role of fibroblast growth factor 23 in health and in chronic kidney disease, and the impact of elevated fibroblast growth factor 23 levels on adverse clinical outcomes in patients with kidney disease.

Current Appointments & Affiliations

Charles Johnson, M.D. Distinguished Professor of Medicine · 2018 - Present Medicine, Nephrology, Medicine
Adjunct Professor in the Department of Medicine · 2024 - Present Medicine, Nephrology, Medicine
Chief of Nephrology · 2016 - Present Medicine, Nephrology, Medicine
Professor in Population Health Sciences · 2018 - Present Population Health Sciences, Basic Science Departments
Member in the Duke Clinical Research Institute · 2017 - Present Duke Clinical Research Institute, Institutes and Centers

Education, Training & Certifications

Harvard Medical School · 2002 M.Med.Sc.
State University of New York, Brooklyn · 1996 M.D.